Journal of Diabetes Investigation · 2022 · 14 citations · 29 references
MedicineEndocrinologyPharmacologyInflammationRenal PathophysiologySignal TransductionDiabetes MellitusDiabetic Kidney DiseaseDiabetic NephropathyInflammasome ActivationRenal DiseaseRenal PharmacologyDiabetes-related ComplicationsDiabetic Kidney Disease ProgressionInflammasome RegulationNlr Family Pyrin Domain-containing 3 InflammasomeNlrp3 InflammasomeReceptors
Abstract Aims/Introduction Nucleotide‐binding oligomerization domain‐like receptor family pyrin domain containing 3 (NLRP3) inflammasomes produce IL‐18 upon being activated by various stimuli via the P2 receptors. Previously, we showed that serum and urine IL‐18 levels are positively associated with albuminuria in patients with type 2 diabetes, indicating the involvement of inflammasome activation in the pathogenesis of diabetic kidney disease (DKD). In the present study, we investigated whether the administration of suramin, a nonselective antagonist of the P2 receptors, protects diabetic KK.Cg‐ A y /TaJcl (KK‐Ay) mice against DKD progression. Materials and Methods Suramin or saline was administered i.p. to KK‐Ay and C57BL/6J mice once every 2 weeks for a period of 8 weeks. Mouse mesangial cells (MMCs) were stimulated with ATP in the presence or absence of suramin. Results Suramin treatment significantly suppressed the increase in the urinary albumin‐to‐creatinine ratio, glomerular hypertrophy, mesangial matrix expansion, and glomerular fibrosis in KK‐Ay mice. Suramin also suppressed the upregulation of NLRP3 inflammasome‐related genes and proteins in the renal cortex of KK‐Ay mice. P2X4 and P2X7 receptors were significantly upregulated in the isolated glomeruli of KK‐Ay mice and mainly distributed in the glomerular mesangial cells of KK‐Ay mice. Although neither ATP nor suramin affected NLRP3 expression in MMCs, suramin inhibited ATP‐induced NLRP3 complex formation and the downstream expression of caspase‐1 and IL‐18 in MMCs. Conclusions These results suggest that the NLRP3 inflammasome is activated in a diabetic kidney and that inhibition of the NLRP3 inflammasome with suramin protects against the progression of early stage DKD.
29
The Burden of Mortality Attributable to Diabetes
Gojka Roglić, Nigel Unwin, Peter H. Bennett et al. · Diabetes Care · 2005 · 820 citations · Full text
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Hyemi Lee, Jwa-Jin Kim, Hyun Jin Kim et al. · Diabetes · 2012 · 738 citations · Full text